Sarcopenia in daily practice: assessment and management

BMC Geriatrics

Volumn 16, Issue 1, 2016, Pages 1-10

  Beaudart, Charlotte ^a   McCloskey, Eugène ^b,c   Bruyère, Olivier ^a   Cesari, Matteo ^d,e   Rolland, Yves ^e   Rizzoli, René ^f   Araujo de Carvalho, Islène ^g   Amuthavalli Thiyagarajan, Jotheeswaran ^g   Bautmans, Ivan ^h   Bertière, Marie Claude ⁱ   Brandi, Maria Luisa ^j   Al Daghri, Nasser M ^k   Burlet, Nansa ^a   Cavalier, Etienne ^l   Cerreta, Francesca ^m   Cherubini, Antonio ⁿ   Fielding, Roger ^o   Gielen, Evelien ^p   Landi, Francesco ^q   Petermans, Jean ^l   Reginster, Jean Yves ^a   Visser, Marjolein ^r,s   Kanis, John ^b,t   Cooper, Cyrus ^u,v   more..

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

ⁱ Centre de Recherche et d'Information Nutritionnelles   (France)

^j UNIVERSITY OF FLORENCE   (Italy)

^k KING SAUD UNIVERSITY   (Saudi Arabia)

^l UNIVERSITY OF LIÈGE   (Belgium)

^m Human Medicines Research Development Support Division Scientific Advice   (United Kingdom)

ⁿ INRCA   (Italy)

^o TUFTS UNIVERSITY   (United States)

^p UNIVERSITY OF LEUVEN   (Belgium)

^q CATHOLIC UNIVERSITY   (Italy)

^r VU UNIVERSITY AMSTERDAM   (Netherlands)

^s VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^t AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^u UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^v UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Assessment; Daily practice; Management; Sarcopenia; Tools

Indexed keywords

AGED; AGING; DISABILITY; EXERCISE TEST; FALLING; HUMAN; META ANALYSIS; MUSCLE STRENGTH; ORGAN SIZE; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; QUESTIONNAIRE; RISK ASSESSMENT; SARCOPENIA; UTILIZATION;

ABSORPTIOMETRY, PHOTON; ACCIDENTAL FALLS; AGED; AGING; DISABILITY EVALUATION; EXERCISE TEST; HUMANS; MUSCLE STRENGTH; ORGAN SIZE; PRIMARY HEALTH CARE; RISK ASSESSMENT; SARCOPENIA; SURVEYS AND QUESTIONNAIRES;

EID: 84992052960     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/s12877-016-0349-4     Document Type: Article

References (84)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-1S.
2. Muscaritoli M, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr. 2010;29:154-9.
3. Cruz-Jentoft AJ, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-23.
4. Fielding RA, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-56.
5. Dam T-T, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69:584-90.
6. Morley JE, et al. Sarcopenia with limited mobility: an International Consensus. J Am Med Dir Assoc. 2011;12:403-9.
7. Studenski SA, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547-58.
8. Baumgartner RN, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-63.
9. Cooper C, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int. 2012;23:1839-48.
10. Chen L-K, et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95-101.
11. Cruz-Jentoft AJ. et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014. doi:10.1093/ageing/afu115
12. Bischoff-Ferrari HA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015. doi:10.1007/s00198-015-3194-y.
13. Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: Burden and challenges for Public Health. 2014. Archives of Public Health. Arch Public Heal. 2014;72:45.
14. Rizzoli R, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93:101-20.
15. Lauretani F, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851-60.
16. Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatr Med. 2011;27:387-99.
17. Lang T, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21:543-59.
18. Landi F, et al. Sarcopenia and frailty: From theoretical approach into clinical practice. 2016. http://emvmsa1a.jouve-hdi.com/en/article/1029882.
19. Landi F, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31:652-8.
20. Denison HJ, Cooper C, Sayer AA, Robinson SM. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging. 2015;10:859-69.
21. Molfino A, Gioia G, Rossi Fanelli F, Muscaritoli M. Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials. Amino Acids. 2013;45:1273-92.
22. Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults-a meta-analysis. Med Sci Sports Exerc. 2014;46:1194-203.
23. Cooper C, et al. Tools in the assessment of sarcopenia. Calcif Tissue Int. 2013;93:201-10.
24. Mijnarends DM, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14:170-8.
25. Hiligsmann M, et al. A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:271-82.
26. Rizzoli R, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79:122-32.
27. Bruyère O, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:253-63.
28. Rizzoli R, et al. Management of osteoporosis of the oldest old. Osteoporos Int. 2014;25:2507-29.
29. Arden N, et al. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty. Drugs Aging. 2015;32:525-35.
30. Cooper C, et al. How to define responders in osteoarthritis. Curr Med Res Opin. 2013;29:719-29.
31. Rizzoli R, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013;29:305-13.
32. Kaufman J-M, et al. Treatment of osteoporosis in men. Bone. 2013;53:134-44.
33. Rizzoli R, et al. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int. 2012;23:2567-76.
34. Reginster J-Y, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis Cartilage. 2015. doi:10.1016/j.joca.2015.07.001.
35. Reginster J-Y, et al. Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res. 2015;28:47-58.
36. Hunter S, White M, Thompson M. Techniques to evaluate elderly human muscle function: a physiological basis. J Gerontol Biol Sci. 1998;53:2-4.
37. Beaudart C, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol. 2014;61C:31-7.
38. Cavalier E, Beaudart C, Buckinx F, Bruyère O, Reginster J-Y. Critical analytical evaluation of promising markers for sarcopenia. 2015. http://www.em-consulte.com/en/article/1021209.
39. Mitsiopoulos N, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115-22.
40. Levine JA, et al. Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy X-ray absorptiometry. J Appl Physiol. 2000;88:452-6.
41. Visser M, Fuerst T, Lang T, Salamone L, Harris TB. Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study--Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol. 1999;87:1513-20.
42. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-96.
43. Rush EC, Freitas I, Plank LD. Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr. 2009;102:632-41.
44. Bruyère O, et al. Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey. Eur Geriatr Med. 2016;7:243-6.
45. Landi F, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr. 2010;29:441-7.
46. Landi F, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr. 2014;33:539-44.
47. Rolland Y, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51:1120-4.
48. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982;36:680-90.
49. Kulkarni B, et al. Development and validation of anthropometric prediction equations for estimation of lean body mass and appendicular lean soft tissue in Indian men and women. J Appl Physiol. 2013;115:1156-62.
50. Yu S, et al. An anthropometric prediction equation for appendicular skeletal muscle mass in combination with a measure of muscle function to screen for sarcopenia in primary and aged care. J Am Med Dir Assoc. 2015;16:25-30.
51. Villani AM, et al. Appendicular skeletal muscle in hospitalised hip-fracture patients: development and cross-validation of anthropometric prediction equations against dual-energy X-ray absorptiometry. Age Ageing. 2014;43:857-62.
52. Reiss J, et al. Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry. BMC Geriatr. 2016;16:52.
53. Kim M, Kim H. Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older. Eur J Clin Nutr. 2013;67:395-400.
54. Kim M, Shinkai S, Murayama H, Mori S. Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population. Geriatr Gerontol Int. 2015;15:1013-22.
55. Buckinx F, et al. Concordance between muscle mass assessed by bioelectrical impedance analysis and by dual energy X-ray absorptiometry: a cross-sectional study. BMC Musculoskelet Disord. 2015;16:60.
56. Stevens PJ, et al. Is grip strength a good marker of physical performance among community-dwelling older people? J Nutr Heal Aging. 2012;16:769-74.
57. Bohannon RW, Magasi SR, Bubela DJ, Wang Y-C, Gershon RC. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve. 2012;46:555-8.
58. Roberts HC, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40:423-9.
59. Bean JF, et al. The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc. 2002;50:461-7.
60. Dodds RM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9:e113637.
61. Anjum SN, Choudary P, Dimri R, Ankarath S. Comparative evaluation of grip and pinch strength in an Asian and European population. Hand Ther. 2012;17:11-4.
62. Brown M, Sinacore DR, Binder EF, Kohrt WM. Physical and performance measures for the identification of mild to moderate frailty. J Gerontol A Biol Sci Med Sci. 2000;55:M350-5.
63. Callahan D, Phillips E, Carabello R, Frontera WR, Fielding RA. Assessment of lower extremity muscle power in functionally-limited elders. Aging Clin Exp Res. 2007;19:194-9.
64. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70:113-9.
65. Karpman C, Lebrasseur NK, Depew ZS, Novotny PJ, Benzo RP. Measuring gait speed in the out-patient clinic: methodology and feasibility. Respir Care. 2014;59:531-7.
66. National Institute on Aging, Laboratory of Epidemiology, Demography, and Biometry. https://www.nia.nih.gov/.
67. Bean JF, Kiely DK, LaRose S, Alian J, Frontera WR. Is Stair Climb Power a Clinically Relevant Measure of Leg Power Impairments in At-Risk Older Adults? Arch Phys Med Rehabil. 2007;88:604-9.
68. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev. 1996;54:S59-65.
69. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531-2.
70. Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc. 2014;15:630-4.
71. Goodman MJ, et al. Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle. 2013;4:187-97.
72. Visvanathan R, et al. Appendicular skeletal muscle mass: development and validation of anthropometric prediction equations. 2012. https://digital.library.adelaide.edu.au/dspace/handle/2440/76238.
73. Ishii S, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014;14 Suppl 1:93-101.
74. Sayer AA, et al. Type 2 Diabetes, Muscle Strength, and Impaired Physical Function: The tip of the iceberg? Diabetes Care. 2005;28:2541-2.
75. Reginster J-Y, Beaudart C, Buckinx F, Bruyère O. Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care. 2015. doi:10.1097/MCO.0000000000000230.
76. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819-29.
77. Peterson MD, Sen A, Gordon PM. Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Med Sci Sport Exerc. 2011;43:249-58.
78. Sahni S, Mangano KM, Hannan MT, Kiel DP, McLean RR. Higher Protein Intake Is Associated with Higher Lean Mass and Quadriceps Muscle Strength in Adult Men and Women. J Nutr. 2015;145:1569-75.
79. Genaro Pde S, Pinheiro Mde M, Szejnfeld VL, Martini LA. Dietary protein intake in elderly women: association with muscle and bone mass. Nutr Clin Pract. 2015;30:283-9.
80. Bauer J, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14:542-59.
81. Deer RR, Volpi E. Protein intake and muscle function in older adults. Curr Opin Clin Nutr Metab Care. 2015;18:248-53.
82. Gryson C, et al. Four-month course of soluble milk proteins interacts with exercise to improve muscle strength and delay fatigue in elderly participants. J Am Med Dir Assoc. 2014;15:958.e1-9.
83. Finger D, et al. Effects of protein supplementation in older adults undergoing resistance training: a systematic review and meta-analysis. Sports Med. 2015;45:245-55.
84. Beaudart C. et al. The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab jc20141742 (2014). doi:10.1210/jc.2014-1742